GSK results on new hep B drug: overall 19% functional cure
hepatitissa.asn.au/communitynew...
@suwang88.bsky.social @hepatitisaustralia.bsky.social @hepbvoicesau.bsky.social @worldhepalliance.bsky.social
Pharmaceutical giant, GSK, who seem to be leading the field in developing a hepatitis B functional cure, has finally presented the results on their new drug, bepirovirsen. The 254 million…
